5 unknown. 5 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Unknown 5 |
| Phase 2 | 2 | Unknown 2 |
Follow Precancerous Condition: new trials by email Literature Review of Precancerous Condition trials Research Report on Precancerous Condition
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus questionnaire administration, comparison of screening methods, diagnostic endoscopic procedure - Esophageal Cancer, Precancerous Condition | Phase 1 / Phase 2 | Unknown | US Department of Veterans Affairs | 50 | 2009-05-01 | 2014-01-10 |
| Cidofovir in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Receiving Chemotherapy and Radiation Therapy carboplatin, cidofovir, protein expression analysis - Cervical Cancer, Precancerous Condition | Phase 1 | Unknown | Gustave Roussy, Cancer Campus, Grand Paris | 24 | 2008-04-01 | 2010-01-28 |
| Erlotinib in Treating Patients With Barrett Esophagus erlotinib hydrochloride, laboratory biomarker analysis, biopsy - Esophageal Cancer, Precancerous Condition | Phase 1 | Unknown | Kansas City Veteran Affairs Medical Center | 25 | 2007-07-01 | 2013-09-17 |
| Beta Alethine in Treating Patients With Myeloma beta alethine - Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition | Phase 1 / Phase 2 | Unknown | LifeTime Pharmaceuticals | 2000-08-01 | 2013-12-18 | |
| Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer sargramostim, amifostine trihydrate, carboplatin - Chronic Myeloproliferative Disorders, Drug/Agent Toxicity by Tissue/Organ | Phase 1 | Unknown | The Cleveland Clinic | 30 | 1997-11-01 | 2013-12-19 |
Precancerous Conditions (5) · Barrett Esophagus (2) · Esophageal Neoplasms (2) · Monoclonal Gammopathy of Undetermined Significance (2) · Multiple Myeloma (2) · Neoplasms, Plasma Cell (2) · Adenocarcinoma Of Esophagus (1) · Blast Crisis (1) · Burkitt Lymphoma (1) · Drug-Related Side Effects and Adverse Reactions (1) · Hodgkin Disease (1) · Immunoblastic Lymphadenopathy (1) · Immunoglobulin Light-chain Amyloidosis (1) · Leukemia (1) · Leukemia, Biphenotypic, Acute (1)
Neoplasms (5) · Neoplasms by Site (4) · Blood Protein Disorders (2) · Cardiovascular Diseases (2) · DNA Virus Infections (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Disease Attributes (2) · Esophageal Diseases (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Head and Neck Neoplasms (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2)
Carboplatin (2) · Amifostine (1) · Biopsy (1) · Brachytherapy (1) · Cidofovir (1) · Cyclophosphamide (1) · Endoscopy (1) · Endoscopy, Digestive System (1) · Erlotinib Hydrochloride (1) · Radiotherapy (1) · alethine (1) · sargramostim (1)
Gustave Roussy, Cancer Campus, Grand Paris (1) · Kansas City Veteran Affairs Medical Center (1) · LifeTime Pharmaceuticals (1) · The Cleveland Clinic (1) · US Department of Veterans Affairs (1)
United States (4) · France (1)
Eric Deutsch, MD (1) · George Thomas Budd, MD (1) · Jason A. Dominitz, MD (1) · Joaquina C. Baranda, MD (1) · Suzin Mayerson, PhD (1)